Trial intelligence / Profile preview

Intensified vs Standard Mycophenolate Sodium in Renal Transplant

NCT00419926Phase 4Completed

Sponsor
Novartis
Start
Dec 2006
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate sodium in kidney transplantation, sponsored by Novartis. Started Dec 2006; status: completed.

02

Drugs

mycophenolate sodium
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT00419926.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00419926.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call